Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alkyl phosphocholines: toxicity and anticancer properties.

C Muschiol1, M R Berger, B Schuler

  • 1Institute of Toxicology and Chemotherapy, German Cancer Research Center, Heidelberg, Federal Republic of Germany.

Lipids
|November 1, 1987
PubMed
Summary

Hexadecylphosphocholine (HPC), a novel chemotherapeutic, showed toxicity in rats but demonstrated therapeutic effects against methylnitrosourea-induced mammary carcinoma. Further research is needed to explore its potential in cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression.

Oncogene·2017
Same author

Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms.

Oncogene·2017
Same author

Foreword.

Lipids·2016
Same author

Toggling the Local Electric Field with an Embedded Adatom Switch.

Nano letters·2015
Same author

Development and application of three-dimensional skin equivalents for the investigation of percutaneous worm invasion.

Experimental parasitology·2015
Same author

Pharmacological insight into the anti-inflammatory activity of sesquiterpene lactones from Neurolaena lobata (L.) R.Br. ex Cass.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2014

Area of Science:

  • Pharmacology
  • Oncology
  • Toxicology

Background:

  • Hexadecylphosphocholine (HPC) represents a new class of antineoplastic chemotherapeutics.
  • Understanding its toxicity and efficacy is crucial for clinical development.

Purpose of the Study:

  • To investigate the acute and subacute toxicity of HPC in rats.
  • To evaluate the antineoplastic activity of HPC against various tumor models.

Main Methods:

  • Acute and subacute toxicity studies were conducted in rats to determine LD50 and maximum tolerable dose.
  • Antineoplastic activity was assessed using methylnitrosourea-induced mammary carcinoma, transplantable mammary carcinomas, benzo(a)pyrene-induced sarcomas, MXT mammary carcinoma, Walker 256 carcinosarcoma, and acetoxymethylmethylnitrosamine-induced colonic tumors.

Related Experiment Videos

Main Results:

  • The LD50 of HPC in rats was 606 mumol/kg, with a maximum tolerable dose of 39 mumol/kg over four weeks.
  • Toxicity symptoms included enteritis, liver spider cell activation, splenic hemosiderosis, and reversible transaminase increase.
  • HPC exhibited the best therapeutic effect on methylnitrosourea-induced mammary carcinoma in rats, with low-grade sensitivity observed in two transplantable rat mammary carcinomas and benzo(a)pyrene-induced rat sarcomas.

Conclusions:

  • HPC demonstrates a specific antineoplastic activity profile, with notable efficacy against MNU-induced rat mammary carcinoma.
  • Certain tumor models, including MXT mammary carcinoma, Walker 256 carcinosarcoma, and nitrosamine-induced colonic tumors, showed no chemosensitivity to HPC.
  • Further investigation into HPC's mechanism of action and therapeutic window is warranted.